Literature DB >> 16787868

Epidemiology and pathologic features of Hodgkin lymphoma.

Shin-ichi Nakatsuka1, Katsuyuki Aozasa.   

Abstract

Hodgkin lymphoma (HL) has unique epidemiologic characteristics. The variation in incidence according to age, sex, race, socioeconomic status, and histologic subtype suggests an etiologic heterogeneity for this tumor. Epidemiologic studies have shown that both genetic and environmental factors play a role in the pathogenesis of HL. HL is one of the Epstein-Barr virus-associated lymphomas, but the oncogenetic mechanism of HL remains to be elucidated. Recent advances in molecular biology have revealed the peculiar nature of the nodular lymphocyte predominant subtype, and as a result this disease is separated from classic types of HL in the new World Health Organization classification. Reed-Sternberg (RS) cells and lymphocytic and/or histiocytic (L&H) cells originate from germinal center B-cells. Loss of the B-cell phenotype due to down-regulation of several B-cell-specific transcription factors is characteristic of RS cells in classic HL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787868     DOI: 10.1532/IJH97.05184

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease.

Authors:  V Seitz; M Hummel; T Marafioti; I Anagnostopoulos; C Assaf; H Stein
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

2.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells.

Authors:  A Braeuninger; R Küppers; J G Strickler; H H Wacker; K Rajewsky; M L Hansmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.

Authors:  H Stein; T Marafioti; H D Foss; H Laumen; M Hummel; I Anagnostopoulos; T Wirth; G Demel; B Falini
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

4.  Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.

Authors:  P A Rowlings; R E Curtis; J R Passweg; H J Deeg; G Socié; L B Travis; D W Kingma; E S Jaffe; K A Sobocinski; M M Horowitz
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

5.  International patterns in the occurrence of Hodgkin's disease in children and young adult males.

Authors:  G J Macfarlane; T Evstifeeva; P Boyle; S Grufferman
Journal:  Int J Cancer       Date:  1995-04-10       Impact factor: 7.396

6.  HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease.

Authors:  Lea C Harty; Albert Y Lin; Alisa M Goldstein; Elaine S Jaffe; Mary Carrington; Margaret A Tucker; William S Modi
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

7.  Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.

Authors:  A Diepstra; M Niens; E Vellenga; G W van Imhoff; I M Nolte; M Schaapveld; G van der Steege; A van den Berg; R E Kibbelaar; G J te Meerman; S Poppema
Journal:  Lancet       Date:  2005 Jun 25-Jul 1       Impact factor: 79.321

8.  Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy.

Authors:  O W Kamel; L M Weiss; M van de Rijn; T V Colby; D W Kingma; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

Review 9.  Epidemiology of Hodgkin's disease: a review.

Authors:  R A Cartwright; Gillian Watkins
Journal:  Hematol Oncol       Date:  2004-03       Impact factor: 5.271

10.  Childbearing and the risk of Hodgkin's disease.

Authors:  M Lambe; C C Hsieh; S W Tsaih; J Adami; B Glimelius; H O Adami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-09       Impact factor: 4.254

View more
  15 in total

1.  UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control study.

Authors:  L Grandin; L Orsi; X Troussard; A Monnereau; C Berthou; P Fenaux; G Marit; P Soubeyran; F Huguet; N Milpied; M Leporrier; D Hemon; J Clavel
Journal:  Cancer Causes Control       Date:  2007-11-27       Impact factor: 2.506

2.  Birth weight and risk of paediatric Hodgkin lymphoma: Findings from a population-based record linkage study in California.

Authors:  Corey Triebwasser; Rong Wang; Andrew T DeWan; Catherine Metayer; Libby Morimoto; Joseph L Wiemels; Nina Kadan-Lottick; Xiaomei Ma
Journal:  Eur J Cancer       Date:  2016-11-01       Impact factor: 9.162

3.  Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood.

Authors:  Casey Crump; Kristina Sundquist; Weiva Sieh; Marilyn A Winkleby; Jan Sundquist
Journal:  Am J Epidemiol       Date:  2012-11-21       Impact factor: 4.897

4.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

5.  Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case-Control Study.

Authors:  Connor Graham; Catherine Metayer; Libby M Morimoto; Joseph L Wiemels; Arfan Siddique; Mengyang Di; Rozalyn L Rodwin; Nina S Kadan-Lottick; Xiaomei Ma; Rong Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

6.  Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients.

Authors:  Xin Huang; Anke van den Berg; Zifen Gao; Lydia Visser; Ilja Nolte; Hans Vos; Bouke Hepkema; Wierd Kooistra; Sibrand Poppema; Arjan Diepstra
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

Review 7.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

8.  Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China.

Authors:  Xin Huang; Ilja Nolte; Zifen Gao; Hans Vos; Bouke Hepkema; Sibrand Poppema; Anke van den Berg; Arjan Diepstra
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

9.  Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.

Authors:  Qun-Pei Yang; Wen-Yan Zhang; Jian-Bo Yu; Sha Zhao; Huan Xu; Wei-Ya Wang; Cheng-Feng Bi; Zhuo Zuo; Xiao-Qing Wang; Juan Huang; Lin Dai; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-08-22       Impact factor: 2.644

10.  Geographic risk modeling of childhood cancer relative to county-level crops, hazardous air pollutants and population density characteristics in Texas.

Authors:  James A Thompson; Susan E Carozza; Li Zhu
Journal:  Environ Health       Date:  2008-09-25       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.